Cargando…

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation

AIMS: Since 2008, KRAS mutation status in exon 2 has been used to predict response to anti-EGFR therapies. Recent evidence has demonstrated that NRAS status is also predictive of response. Several retrospective ‘extended RAS’ analyses have been performed on clinical trial material. Despite this, are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richman, Susan D, Fairley, Jennifer, Butler, Rachel, Deans, Zandra C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256378/ https://www.ncbi.nlm.nih.gov/pubmed/27681846 http://dx.doi.org/10.1136/jclinpath-2016-203822

Ejemplares similares

RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009–2016)
por: Richman, Susan D., et al.
Publicado: (2017)

Results of the UK NEQAS for Molecular Genetics reference sample analysis
por: Richman, Susan D, et al.
Publicado: (2018)

The history and evolution of HLA typing external proficiency testing schemes in UK NEQAS for H&I
por: De’Ath, A., et al.
Publicado: (2023)

UK NEQAS ICC & ISH Ki-67 Data Reveal Differences in Performance of Primary Antibody Clones
por: Parry, Suzanne, et al.
Publicado: (2021)

Development of a United Kingdom National External Quality Assessment Scheme (UK NEQAS) for HIV point of care testing
por: Abdul-Khaliq, Catherine
Publicado: (2011)

Prospective longitudinal study of tobacco company adaptation to standardised packaging in the UK: identifying circumventions and closing loopholes
por: Evans-Reeves, Karen A, et al.
Publicado: (2019)

Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey
por: Cartwright, Ashley, et al.
Publicado: (2023)

The electrocardiogram for sepsis: how close are we?
por: Levy, Mitchell M
Publicado: (2007)

Biomarkers in psychiatry: how close are we?
por: Kobeissy, Firas, et al.
Publicado: (2013)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
por: Sakai, Kazuko, et al.
Publicado: (2015)

Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012)

How close are we to therapies for Sanfilippo disease?
por: Gaffke, Lidia, et al.
Publicado: (2017)

Standardisation and controls, why can’t we overcome the hurdles?
por: Niesters, Hubert G.M., et al.
Publicado: (2004)

Ras Isoforms from Lab Benches to Lives—What Are We Missing and How Far Are We?
por: Nair, Arathi, et al.
Publicado: (2021)

How standardised are antibiotic regimens in otologic surgery?
por: Lui, Justin T., et al.
Publicado: (2023)

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
por: Deans, Zandra C., et al.
Publicado: (2019)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Closing Yield Gaps: How Sustainable Can We Be?
por: Pradhan, Prajal, et al.
Publicado: (2015)

Vaccines for Perinatal and Congenital Infections—How Close Are We?
por: Singh, Tulika, et al.
Publicado: (2020)

Molecular Screening for Urothelial Cancer: How Close We Are?
por: Michas, Athanasios, et al.
Publicado: (2023)

How Do We Determine the Efficacy of an Antibacterial Surface? A Review of Standardised Antibacterial Material Testing Methods
por: Cunliffe, Alexander J., et al.
Publicado: (2021)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

How can we get intelligent systems close to experiments?
por: Böck, R K, et al.
Publicado: (1988)

Reprogramming human cells to naïve pluripotency: how close are we?
por: Bates, Lawrence E, et al.
Publicado: (2017)

Bioengineering adult human heart tissue: How close are we?
por: Mills, Richard J., et al.
Publicado: (2019)

How close are we to the temperature tipping point of the terrestrial biosphere?
por: Duffy, Katharyn A., et al.
Publicado: (2021)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

National Survey Highlights the Urgent Need for Standardisation of Embryo Transfer Techniques in the UK
por: Nancarrow, Lewis, et al.
Publicado: (2021)

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)
por: Fenizia, Francesca, et al.
Publicado: (2021)

A review of e-textiles in neurological rehabilitation: How close are we?
por: McLaren, Ruth, et al.
Publicado: (2016)

Throwing darts in ICU: how close are we in estimating energy requirements?
por: Grguric, Laryssa, et al.
Publicado: (2020)

How close are we to hepatitis C virus elimination in Central Europe?
por: Flisiak, Robert, et al.
Publicado: (2020)

Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?
por: Kahraman, Emine, et al.
Publicado: (2022)

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
por: Earl, Julie, et al.
Publicado: (2023)

Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer
por: Sasaki, Yusuke, et al.
Publicado: (2016)

Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus
por: Shaikh, M. Guftar, et al.
Publicado: (2023)

Extending the screening programme: how we did it and lived to tell the tale!
por: Gilks, V, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_lss2r3h8jmpd5dm55j9mdf8qnh